Category
Cancer
Sub Category
Melanoma
Study Name
ECOG E1609: A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High Dose Interferon a-2b for Resected High Risk Melanoma
Principal Investigator
Gordan Srkalovic MD, PhD
Study Information
Contact for Questions
Sparrow Cancer Center 800-968-5570

Site view: at a glance